Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Merlin C Thomas

Showing results (81-90 of 171) with videos related to

Pageof 18
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|June 24, 2004
The role of advanced glycation in reduced organic cation transport associated with experimental diabetesMerlin C Thomas, Christos Tikellis, Phillip Kantharidis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 8, 2006
Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysisMatthew A Roberts, Merlin C Thomas, Dharsh Fernando, et al.
American Journal of Physiology. Renal Physiology|May 11, 2012
High nephron endowment protects against salt-induced hypertensionKenneth A Walker, Xiaochu Cai, Georgina Caruana, et al.
Current Cardiology Reviews|June 10, 2016
Phase 4 Studies in Heart Failure - What is Done and What is Needed?Pupalan Iyngkaran, Danny Liew, Peter McDonald, et al.
Clinical Science (London, England : 1979)|September 27, 2005
Diastolic dysfunction is associated with anaemia in patients with Type II diabetesPiyush M Srivastava, Merlin C Thomas, Paul Calafiore, et al.
Kidney International|December 1, 2005
Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cellsMandy L Ballinger, Merlin C Thomas, Julie Nigro, et al.
Atherosclerosis|January 12, 2007
Increased atherosclerosis following treatment with a dual PPAR agonist in the ApoE knockout mouseAnna C Calkin, Terri J Allen, Markus Lassila, et al.
Circulation Research|March 10, 2012
Distinguishing hyperglycemic changes by Set7 in vascular endothelial cellsJun Okabe, Christian Orlowski, Aneta Balcerczyk, et al.
Clinical Medicine Insights. Cardiology|October 25, 2016
A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart FailurePupalan Iyngkaran, Samia R Toukhsati, Merlin C Thomas, et al.
Clinical Science (London, England : 1979)|May 24, 2012
TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammationStella Bernardi, Giorgio Zauli, Christos Tikellis, et al.
Pageof 18

Showing results (81-90 of 171) with videos related to

Sort By:
Pageof 18
The Journal of Pharmacology and Experimental Therapeutics|June 24, 2004
The role of advanced glycation in reduced organic cation transport associated with experimental diabetesMerlin C Thomas, Christos Tikellis, Phillip Kantharidis, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|March 8, 2006
Low molecular weight advanced glycation end products predict mortality in asymptomatic patients receiving chronic haemodialysisMatthew A Roberts, Merlin C Thomas, Dharsh Fernando, et al.
American Journal of Physiology. Renal Physiology|May 11, 2012
High nephron endowment protects against salt-induced hypertensionKenneth A Walker, Xiaochu Cai, Georgina Caruana, et al.
Current Cardiology Reviews|June 10, 2016
Phase 4 Studies in Heart Failure - What is Done and What is Needed?Pupalan Iyngkaran, Danny Liew, Peter McDonald, et al.
Clinical Science (London, England : 1979)|September 27, 2005
Diastolic dysfunction is associated with anaemia in patients with Type II diabetesPiyush M Srivastava, Merlin C Thomas, Paul Calafiore, et al.
Kidney International|December 1, 2005
Glycated and carboxy-methylated proteins do not directly activate human vascular smooth muscle cellsMandy L Ballinger, Merlin C Thomas, Julie Nigro, et al.
Atherosclerosis|January 12, 2007
Increased atherosclerosis following treatment with a dual PPAR agonist in the ApoE knockout mouseAnna C Calkin, Terri J Allen, Markus Lassila, et al.
Circulation Research|March 10, 2012
Distinguishing hyperglycemic changes by Set7 in vascular endothelial cellsJun Okabe, Christian Orlowski, Aneta Balcerczyk, et al.
Clinical Medicine Insights. Cardiology|October 25, 2016
A Review of the External Validity of Clinical Trials with Beta-Blockers in Heart FailurePupalan Iyngkaran, Samia R Toukhsati, Merlin C Thomas, et al.
Clinical Science (London, England : 1979)|May 24, 2012
TNF-related apoptosis-inducing ligand significantly attenuates metabolic abnormalities in high-fat-fed mice reducing adiposity and systemic inflammationStella Bernardi, Giorgio Zauli, Christos Tikellis, et al.
Pageof 18